Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M410Revenue $M156Net Margin (%)-46.5Z-Score0.6
Enterprise Value $M357EPS $-1.0Operating Margin %-20.7F-Score4
P/E(ttm))0Cash Flow Per Share $0.7Pre-tax Margin (%)-25.0Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %0Current Ratio2.1Lower Leverage y-yN
Price/Cash Flow16.2y-y EBITDA Growth Rate %0ROA % (ttm)-17.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-29.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.8ROI % (ttm)5.7Gross Margin Increase y-yY

Gurus Latest Trades with SPPI

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPPIJohn Burbank 2012-12-31 Sold Out -0.13%$10.64 - $12.31
($11.39)
$ 6.23-45%Sold Out0
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 6.23-45%Sold Out0
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 6.23-45%Sold Out0
SPPIJohn Burbank 2012-09-30 Buy 0.13%$11.6 - $17.05
($13.85)
$ 6.23-55%New holding, 250000 sh.250,000
SPPIJoel Greenblatt 2012-09-30 Buy 0.02%$11.6 - $17.05
($13.85)
$ 6.23-55%New holding, 19901 sh.19,901
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPPI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SPPI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2013-03-05Sell5,000$11.5-44.78view
MAIDA ANTHONY E IIIDirector 2013-02-05Sell5,000$12.25-48.16view
MAIDA ANTHONY E IIIDirector 2013-01-02Sell5,000$11.42-44.4view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-12-31Sell378,343$11.29-43.76view
MAIDA ANTHONY E IIIDirector 2012-12-04Sell5,000$11.65-45.49view
Keller Joseph KennethEVP & COO 2012-11-12Buy10,000$10.95-42.01view
MAIDA ANTHONY E IIIDirector 2012-11-01Sell5,000$11.09-42.74view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-10-09Sell11,350$12.5-49.2view
MAIDA ANTHONY E IIIDirector 2012-10-02Sell5,000$11.8-46.19view
Scott Brett LActing CFO 2012-10-01Sell6,000$12-47.08view

Press Releases about SPPI :

    Quarterly/Annual Reports about SPPI:

    News about SPPI:

    Articles On GuruFocus.com
    http://seekingalpha. Aug 14 2012 
    Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
    5 Stocks Exceeding Expectations In 2012 Mar 31 2012 
    Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
    Spectrum Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
    Weekly CFO Buys Highlight: CNYD, PRWT, ANCB, SPPI, SPAX Jan 30 2011 
    Weekly CFO Buys Highlight: FUL, SPPI, GRF, BPAX Jan 24 2011 
    Weekly Top Insider Buys: NPBC, FUL, GAM, SHLM, SPPI Jan 23 2011 
    Spectrum Pharmaceuticals Inc. (SPPI) CFO Brett L Scott buys 4,000 Shares Jan 21 2011 
    Spectrum Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 

    More From Other Websites
    Nasdaq stocks posting largest percentage decreases Feb 25 2015
    Spectrum Pharmaceuticals (SPPI) Stock Plunges to One-Year Low on Court's Fusilev Patent Ruling Feb 23 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Dish, Valeant, Spectrum Pharma Feb 23 2015
    SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure Feb 23 2015
    Spectrum Pharma downgraded by ROTH Capital Feb 23 2015
    SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 20 2015
    Spectrum Pharmaceuticals to Present Corporate Update at the 2015 RBC Capital Markets' Global... Feb 20 2015
    Spectrum Pharmaceuticals to Present Corporate Update at the 2015 RBC Capital Markets' Global... Feb 20 2015
    Spectrum Pharmaceuticals Announces Fourth Quarter 2014 Financial Results and Analyst Day Feb 17 2015
    Spectrum Pharmaceuticals Announces Fourth Quarter 2014 Financial Results and Analyst Day Feb 17 2015
    Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free)... Feb 12 2015
    Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4? - Analyst Blog Feb 06 2015
    Bulls returning to Spectrum Pharma Feb 04 2015
    Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for... Dec 26 2014
    Spectrum submits blood-cancer drug for FDA approval Dec 26 2014
    Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled™... Dec 26 2014
    Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled™... Dec 26 2014
    Market's most shorted stocks Dec 10 2014
    Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society... Dec 05 2014
    Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society... Dec 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK